DR. REDDY'S LABORATORIES-ADR (RDY) Forecast, Price Target & Analyst Ratings

NYSE:RDY • US2561352038

Current stock price

13.76 USD
-0.38 (-2.69%)
At close:
13.76 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DR. REDDY'S LABORATORIES-ADR (RDY).

Forecast Snapshot

Consensus Price Target

Price Target
$15.24
+ 10.74% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 7, 2026
Period
Q4 / 2026
EPS Estimate
₹13.38
Revenue Estimate
87.118B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
67.27%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$15.24
Upside
+ 10.74%
From current price of $13.76 to mean target of $15.24, Based on 44 analyst forecasts
Low
$11.63
Median
$14.85
High
$19.07

Price Target Revisions

1 Month
-2.52%
3 Months
2.49%

Price Target Summary

44 Wall Street analysts provided a forecast for the next 12 months for RDY. The average price target is 15.24 USD. This implies a price increase of 10.74% is expected in the next year compared to the current price of 13.76.
The average price target has been revised upward by 2.49% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RDY Current Analyst RatingRDY Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

RDY Historical Analyst RatingsRDY Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30 40

Analyst Ratings Consensus

ChartMill Buy Consensus
67.27%
RDY was analyzed by 44 analysts. The buy percentage consensus is at 67. So analysts seem to be have mildly positive about RDY.
In the previous month the buy percentage consensus was at a similar level.
RDY was analyzed by 44 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-06-05HSBCUpgrade Hold -> Buy
2024-11-06BarclaysMaintains Overweight -> Overweight
2024-07-30BarclaysMaintains Overweight -> Overweight
2024-05-08BarclaysMaintains Overweight -> Overweight
2024-01-29BarclaysMaintains Overweight -> Overweight
2023-06-01BarclaysMaintains Overweight -> Overweight
2022-10-31BarclaysMaintains Overweight
2022-10-25BarclaysMaintains Overweight
2022-09-12BarclaysMaintains Overweight
2022-07-25BarclaysMaintains Overweight
2022-05-24BarclaysMaintains Overweight
2021-11-01BarclaysMaintains Overweight
2021-07-28Prabhudas LilladherMaintains Accumulate
2021-07-28Axis DirectMaintains Buy
2021-07-28ICICI Securities LimitedMaintains Hold
2021-07-28Motilal OswalMaintains Neutral
2021-07-27Axis DirectMaintains Buy
2021-06-23Axis DirectMaintains Buy
2021-05-19Geojit BNP ParibasMaintains Buy
2021-05-17Axis DirectMaintains Buy
2021-05-17HDFC SecuritiesMaintains Accumulate
2021-05-17SMC onlineMaintains
2021-05-15Prabhudas LilladherMaintains Accumulate
2021-05-15ICICI Securities LimitedMaintains Hold
2021-05-15Motilal OswalMaintains Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 7, 2026
Period
Q4 / 2026
EPS Estimate
₹13.38
Revenue Estimate
87.118B
Revenue Q2Q
2.15%
EPS Q2Q
-30.02%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
-0.43%
Revenue (3 Months)
-1.38%
EPS (1 Month)
0.02%
EPS (3 Months)
-3.66%

Next Earnings Summary

RDY is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is 13.38 USD and the consensus revenue estimate is 87.12B USD.
The next earnings revenue estimate has been revised downward by 1.38% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
RDY revenue by date.RDY revenue by date.
246.697B
14.50%		280.111B
13.54%		326.439B
16.54%		349.965B
7.21%		360.321B
2.96%		394.332B
9.44%		419.346B
6.34%		451.606B
7.69%
EBITDA
YoY % growth
RDY ebitda by date.RDY ebitda by date.
65.4B
39.21%		79.334B
21.31%		87.164B
9.87%		82.177B
-5.72%		78.777B
-4.14%		89.818B
14.02%		105.657B
17.63%		114.687B
8.55%
EBIT
YoY % growth
RDY ebit by date.RDY ebit by date.
52.898B
49.73%		64.634B
22.19%		70.127B
8.50%		62.346B
-11.10%		57.073B
-8.46%		67.467B
18.21%		83.406B
23.62%		93.183B
11.72%
Operating Margin
RDY operating margin by date.RDY operating margin by date.
21.44%23.07%21.48%17.81%15.84%17.11%19.89%20.63%
EPS
YoY % growth
RDY eps by date.RDY eps by date.
54.23
90.38%		66.94
23.45%		67.84
1.35%		63.07
-7.04%		56.45
-10.49%		65.39
15.83%		N/AN/A

All data in INR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		13.38
-30.02%		13.91
-18.32%		15.89
-1.78%		17.22
18.51%		17.89
33.70%
Revenue
Q2Q % growth		87.118B
2.15%		91.805B
7.10%		N/AN/AN/A
EBITDA
Q2Q % growth		17.561B
-47.80%		21.246B
-10.15%		N/AN/AN/A
EBIT
Q2Q % growth		14.692B
-11.52%		14.323B
-15.62%		N/AN/AN/A

All data in INR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RDY Yearly Revenue VS EstimatesRDY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100B 200B 300B 400B
RDY Yearly EPS VS EstimatesRDY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20 40 60

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-1.22%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
6.26%
Revenue Next 5 Year
6.56%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
6.94%
EBIT Next 5 Year
9.33%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

DR. REDDY'S LABORATORIES-ADR / RDY Forecast FAQ

What is the average price target for DR. REDDY'S LABORATORIES-ADR (RDY) stock?

44 analysts have analysed RDY and the average price target is 15.24 USD. This implies a price increase of 10.74% is expected in the next year compared to the current price of 13.76.

When does DR. REDDY'S LABORATORIES-ADR (RDY) report earnings?

DR. REDDY'S LABORATORIES-ADR (RDY) will report earnings on 2026-05-07, after the market close.

What are the consensus estimates for RDY stock next earnings?

The consensus EPS estimate for the next earnings of DR. REDDY'S LABORATORIES-ADR (RDY) is 13.38 USD and the consensus revenue estimate is 87.12B USD.

How do analysts rate DR. REDDY'S LABORATORIES-ADR (RDY)?

The consensus rating for DR. REDDY'S LABORATORIES-ADR (RDY) is 67.2727 / 100 . This indicates that analysts generally have a neutral outlook on the stock.